OKYO Pharma Ltd
OKYONext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for OKYO. That does not mean none is planned.
Get an email about OKYO's next catalysts
Track OKYO Pharma (OKYO) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
OK-101 | Phase 2 | Dry Eye Disease | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in OKYO Pharma Ltd's drug pipeline?→
CatalystAlert tracks 1 drug candidate in OKYO Pharma Ltd's (OKYO) pipeline across Phase 2. Its lead program is OK-101 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is OKYO Pharma Ltd's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for OKYO Pharma Ltd (OKYO) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track OKYO biotech catalysts?→
Add OKYO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow OKYO Pharma Ltd's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.